Wednesday, February 23, 2011

A series in off-label marketing

The New York Times recently reported "Four pharmaceutical companies paid more than half of the $19.8 billion in civil and criminal settlements the last 20 years for improper billings to federal and state governments . . ."  Over the next few days, I will be blogging about off-label marketing by drug companies, the staggering amount of money involved (usually paid for by taxpayers), how it's done, and the harm often caused to patients.

No comments:

Post a Comment